Syngen Laboratories Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 24-05-2024
- Paid Up Capital ₹ 0.10 M
as on 24-05-2024
- Company Age 20 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 4.67%
(FY 2020)
- Profit 50.52%
(FY 2020)
- Net Worth 9.16%
(FY 2020)
- Total Assets 6.29%
(FY 2020)
About Syngen Laboratories
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Shobha Thota and Giridhar Thota serve as directors at the Company.
- CIN/LLPIN
U24239TG2004PTC042436
- Company No.
042436
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 Jan 2004
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Syngen Laboratories?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shobha Thota  | Director | 01-Apr-2007 | Current |
| Giridhar Thota | Director | 14-Jan-2004 | Current |
Financial Performance of Syngen Laboratories.
Syngen Laboratories Private Limited, for the financial year ended 2020, experienced modest growth in revenue, with a 4.67% increase. The company also saw a substantial improvement in profitability, with a 50.52% increase in profit. The company's net worth moved up by a moderate rise of 9.16%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Syngen Laboratories?
In 2017, Syngen Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Spica Laboratories Private LimitedActive 19 years 10 monthsShobha Thota and Giridhar Thota are mutual person
Sahasra Laboratories Private LimitedActive 18 years 7 monthsShobha Thota and Giridhar Thota are mutual person
- Sheetal Chemicals Private LimitedActive 20 years 5 months
Shobha Thota and Giridhar Thota are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Syngen Laboratories?
Unlock and access historical data on people associated with Syngen Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Syngen Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Syngen Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
